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Summary  The  microbial  community  on  a  host  relies  on  its  immune  status  and
pathophysiological  condition.  Diabetes  mellitus  is  a metabolic  disorder  associated
with  a  25%  increased  risk  of  developing  foot  infection.  The  pathophysiological  dif-
ferences  between  diabetic  foot  infection  (DFI)  and  non-DFI  patients  may  alter  the
microbial  composition  in  infections.  The  present  study  aims  to  comparatively  ana-
lyze  the  microbes  colonized  in  DFI  and  non-DFI  patients  in  Bangladesh.  Pus  specimens
were  collected  from  67  DFI  and  12  non-DFI  patients  to  investigate  the  bacteria
associated  with  foot  infection.  For  this  investigation,  an  array  of  microbiologi-
cal,  molecular  biological  and  immunological  approaches  were  performed.  Common
bacteria  detected  in  both  DFI/non-DFI  samples  were  Pseudomonas  spp.  (22/29%),
Bacillus  spp.  (12/3%),  Enterobacter  spp.  (22/7%),  Staphylococcus  spp.  (13/13%)
and  Acinetobacter  spp.  (10/10%).  Enterococcus  spp.  (9%)  and  Klebsiella  spp.  (8%)
occurred  only  in  DFI  patients,  whereas  Citrobacter  spp.  (29%)  was  only  detected
in  non-DFI  samples.  The  rate  of  occurrence  of  three  organisms,  namely,  Enterococ-
cus  spp.  |Z|  =  2.2125,  Klebsiella  spp.  |Z|  =  1.732,  Bacillus  spp.  |Z|  =  1.9034,  were  also
statistically  signiﬁcant.  Most  of  the  isolates  from  DFI  patients  were  commonly  resis-
tant  to  the  cephalosporin  (Ceftazidime,  Ceftriazone,  Cefurozime)  and  monobactam
(Aztreonam)  groups  of  antibiotics.  DFI  patients  had  comparatively  higher  C-reactive
protein  (CRP)  levels  than  non-DFI  patients,  and  a  positive  correlation  was  observed
between  multi-antibiotic  resistance  and  CRP  levels  (one  of  the  markers  of  chronic
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subclinical  inﬂammation).  The  present  investigation  implicated  a  complex  association
on  in  DFI  compared  with  non-DFI  with  different  antimicrobial
hich  was  linked  with  CRP  levels.
dulaziz  University  for  Health  Sciences.  Published  by  Elsevier
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also collected  from  these  patients  for  investiga-
tion of  subclinical  inﬂammation.  A  detailed  history
was collected  from  each  of  the  subjects  and  con-of  the  bacterial  populati
resistance  properties,  w
©  2015  King  Saud  Bin  Ab
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Introduction
Diabetes  mellitus  (DM)  is  now  a  major  health  prob-
lem all  over  the  world  and  is  increasing  globally
at an  alarming  rate  [1].  It  has  been  declared
an epidemic  in  developing  countries,  including
Bangladesh [2].  Approximately  347  million  peo-
ple are  suffering  from  DM  worldwide,  which  is
predicted to  double  by  the  year  2025  [3]. The
prevalence of  diabetes  in  Bangladesh  is  increasing
rapidly, leading  to  complications  of  chronic  dia-
betes.  Diabetic  foot  infection  (DFI)  is  one  of  the
most serious  complications  of  DM.  Diabetic  patients
have a  25%  increased  risk  of  developing  a  foot  ulcer
[4].  The  primary  causes  of  DFI  are  microbial  agents,
and their  early  diagnosis  is  essential  for  appropri-
ate antimicrobial  therapy  [5].  Once  an  infection  has
developed in  DFI  patients,  it  is difﬁcult  to  treat
because of  impaired  microvascular  circulation  to
the lower  limb,  which  limits  the  access  of  phago-
cytic cells  and  antibiotics  to  infected  sites  [6].
Common  organisms  reported  in  foot  infection  are
mainly Staphylococcus  spp.  and  Enterococcus  spp.
arising from  the  patient’s  own  body  [7].  Extensive
tissue destruction  and  poor  blood  circulation  are
a result  of  infection  with  Pseudomonas  spp.,  Pro-
teus spp.,  and  Enterococcus  spp.  bacterial  groups
[7].  The  major  predisposing  factor  associated  with
these infections  is  foot  ulceration,  which  is  usually
related to  peripheral  neuropathy  and  peripheral
vascular disease,  and  various  immunological  distur-
bances play  a  secondary  role  in  the  development
of diabetic  foot  ulceration  [8]. Chronic  subclinical
inﬂammation (CSI)  reportedly  has  a  signiﬁcant  asso-
ciation with  the  development  of  acute  diabetic  foot
syndrome  [9]. C-reactive  protein  (CRP)  is  an  acute
phase  protein  whose  concentration  increases  in  the
blood in  response  to  inﬂammation.  CRP  is  a  marker
of CSI  [10].
There is  scant  knowledge  on  the  microbial  com-
position inhabiting  the  DFI  area  and  the  correlation
of these  microbes  to  CSI.  The  present  study  was  per-
formed to  determine  the  bacterial  composition  in
foot lesions  of  DFI  and  non-DFI  patients  and  their
antibiotic  resistance  patterns.  The  investigation
also explores  the  correlation  of  serum  CRP  levels
t
a
oith  microbial  composition  and  resistance  proper-
ies. This  study  is  expected  to  generate  valuable
nformation, which  will  be  helpful  in  the  man-
gement and  prevention  of  foot  infection  in  our
opulation  and  will  help  clinicians  to  select  and
evelop  appropriate  drugs.
aterials and methods
pecimen collection
us  specimens  were  collected  from  infected  foot
ound  sites  of  67  DFI  and  12  non-DFI  patients  from
he Diabetic  Foot  Care  Hospital  (DFCH)  and  Dhaka
edical  College  Hospital  (DMCH),  respectively.  All
f the  diabetic  foot  ulcers  were  included  in  this
tudy irrespective  of  ulcer  grading.  According  to  the
uestionnaire  prepared  for  this  study,  subjects  suf-
ering from  diseases  such  as  cancer,  autoimmune
iseases, cardiovascular  diseases  and  renal  diseases
ere excluded.  Pus  specimens  were  collected  from
he patients  after  ulcer  base  debridement.  To  avoid
ontamination,  foot  wounds  and  tissue  debris  were
horoughly  cleaned  with  sterile  normal  saline  fol-
owed by  gentle  rubbing  of  the  wound  site  with  70%
lcohol prior  to  swabbing  the  pus  sample.  Sterile
otton  swab  sticks  were  moistened  with  sterile  nor-
al saline  before  specimen  collection.  Then,  the
wab sticks  were  extended  deeply  into  the  depth  of
he lesion  to  avoid  contamination  from  the  wound
urroundings.  When  copious  volumes  of  pus  existed,
amples  were  collected  aseptically  by  needle  aspi-
ation to  avoid  major  exogenous  contamination.
fter pus  sample  collection,  the  swabs  were  trans-
orted  to  the  laboratory  by  immersion  to  maintain
septic conditions  (20-ml  test  tube  containing  10  ml
f peptone  water).  The  samples  were  properly
abeled and  immediately  transported  to  the  labora-
ory for  further  investigation.  Blood  samples  wererol patients,  and  the  demographic  data  included
ge, sex,  occupation,  socioeconomic  status,  type
f water  used,  and  type  of  treatment  used.
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tacteriological  study  of  foot  infection  
etermination of total viable
nterobacteriaceae  and resistant bacteria
ounts
ample  tubes  containing  pus  swabs  (67  DFI  and
2 non-DFI)  in  peptone  water  were  incubated  in  a
otary shaker  at  120  rpm  at  37◦C  for  1  h.  The  col-
ected pus  samples  were  serially  diluted  up  to  10−4
ith  sterile  normal  saline  (0.85%).  To  determine
he total  viable  count  (TVC),  the  Enterobacteria-
eae count  (EC)  and  the  resistant  bacteria  count
RBC),  100  l  of  serially  diluted  pus  samples  were
pread on  Nutrient  Agar  (NA)  plates,  MacConkey
gar (MAC)  plates  and  NA  supplemented  with
iproﬂoxacin (CIP,  0.16  g/ml),  Cefotaxime  (CTX,
.0 g/ml)  or  both.  All  of  the  plates  were  incu-
ated at  37 ◦C  overnight,  and  suspected  colonies
ere puriﬁed  on  the  same  media  plate  and  pre-
erved in  20%  glycerol-supplemented  nutrient  (NB)
roth for  further  investigation.
orphological and biochemical isolate
dentiﬁcation
icroscope  observations  and  gram  staining  were
erformed  on  the  isolates.  The  morphological  char-
cteristics  (shape,  size,  edge,  elevation,  form  and
pacity) on  NA  plates  were  recorded.  Biochemical
ests were  performed  for  Gram  positive  bacte-
ia, including  oxidase  (OX),  catalase  (CAT),  Bile
sculin  Agar  (BEA)  tests,  and  for  Gram  negative
acteria, including  Kliger’s  Iron  Agar  (KIA),  motil-
ty, indole  urea  (MIU),  citrate  utilization  (CIT),
arbohydrate  fermentation  (dextrose,  sucrose,  lac-
ose) methyl  red  (MR),  and  Voges-proskauer  (VP)
ests [11].
solate antibiotic sensitivity assay
 standard  agar-disk-diffusion  method  was  used
o perform  antibiotic  susceptibility  assays  using
1 commercially  available  antibiotic  discs  (Oxoid)
hat belong  to  12  groups  [12]. Mueller—Hinton
gar (MHA)  (Oxoid)  media  was  used  for  the  assay.
nhibition  zone  sizes  were  interpreted  by  refer-
ing to  zone  diameter  interpretive  standards  of
he National  Committee  for  Clinical  Laboratory
tandards (NCCLS)  2000  (Supplementary  materials
able  S1).
mpliﬁed ribosomal DNA restriction analysis
ARDRA)
hromosomal  DNA  of  each  isolate  was  extracted
rom a  fresh  bacterial  culture  (<109 cells/mL)  using
R
u
a
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n  ATPTM Genomic  DNA  Mini  Kit  (ATP  Biotech  Inc.,
SA). PCR  was  performed  with  a G2  hot  start  mas-
er mix  (Promega,  USA)  using  universal  primers
7F (5′-AGAGTTTGATCMTGG  CTCAG-3′)  and  1492R
5′-GGTTACCTTGTTAGGACTT-3′) for  the  bacterial
6S rRNA  gene.  The  PCR  reaction  involved  initial
eating at  96 ◦C  for  5 min;  35  cycles  of  denatur-
tion at  94 ◦C  for  1  min  30  s,  annealing  at  55 ◦C
or 1  min  and  extension  at  72 ◦C  for  1  min  30  s;
nd a  ﬁnal  extension  of  10  min  at  72 ◦C.  The  PCR
ubes were  then  stored  at  −20 ◦C  for  analysis.
estriction  digestion  of  the  16S  rRNA  gene  PCR
roduct (approximately  1400  bp)  from  the  isolates
as performed  using  the  HhaI  enzyme  (Bio  labs,
ngland).  The  reaction  mixture  contained  2  l  of
0× buffer,  0.2  l  of  bovine  serum  albumin,  6U  HhaI
nzyme, 2.5  l  of  water,  and  1000  ng  of  PCR  prod-
ct. The  digests  were  visualized  after  1.5%  (wt/vol)
garose gel  electrophoresis.  Different  sizes  of  DNA
arkers (1  Kb  and  100  bp;  Bioneer,  South  Korea)
ere used  to  analyze  the  different  restriction
ragments.
equencing and phylogenetic analysis
he  16S  rRNA  gene  PCR  products  of  the  iso-
ates from  each  ARDRA  group  were  puriﬁed  using
he Wizard  PCR  SV  Gel  and  PCR  Clean-Up  Sys-
em kit  (Promega,  USA)  and  sequenced  (ABI  Prism
130 Genetic  Analyzer,  USA)  using  forward  27F
nd reverse  1492R  primers.  Partial  sequences
ere combined  via  the  SeqMan  Genome  Assembler
DNAstar, USA)  and  were  compared  to  the  GenBank
atabase of  the  National  Center  for  Biotechnology
nformation  (NCBI)  (http://www.ncbi.nlm.nih.gov/
enBank) using  the  Basic  Local  Alignment  Search
ool (BLAST)  to  identify  close  phylogenetic  rela-
ives. Multiple  sequence  alignment  of  the  retrieved
eference sequences  from  NCBI  was  performed
sing ClustalW  [13]  software  and  exported  to  the
olecular  Evolutionary  Genetics  Analysis  (MEGA)
14]  program  for  phylogenetic  tree  construction
sing the  neighbor  joining  algorithm  and  selecting
000  bootstrap  replication.
nalysis of C-reactive protein in blood
amples
 total  of  45  serum  samples  (30  DFI,  10  non-DFI
nd ﬁve  healthy  controls)  were  selected  randomly
o measure  CRP  levels  using  Cardio  Phase  hsCRP
eagent  (Siemens  Health  care  Diagnostics  prod-
cts GmbH,  Germany).  The  reagent  consists  of
 suspension  of  polystyrene  particles  that  had
een coated  with  mouse  monoclonal  antibodies
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(<0.016  g/L)  to  CRP  (BN  *  II/BN  prospect  Sys-
tem). Polystyrene  particles  that  had  been  coated
with monoclonal  antibodies  speciﬁc  for  human  CRP
aggregate  when  mixed  with  samples  containing  CRP.
These aggregates  scatter  a  beam  of  light  that  is
passed through  the  sample.  The  scattered  light
intensity  is  proportional  to  the  relevant  protein
concentration in  the  sample.  The  results  are  eval-
uated by  comparison  with  a  standard  of  known
concentration.
Statistical analysis
To  assess  the  signiﬁcance  of  occurrence  of  the
isolates in  the  DFI  and  non-DFI  groups,  a z-test
calculator for  proportions  was  used  to  investigate
whether the  two  populations  differ  signiﬁcantly
in proportion  (http://www.socscistatistics.com/
tests/ztest/Default2.aspx).  A  two-sample  or  inde-
pendent sample  t-test  was  used  to  compare  the  dif-
ferences in  TVBC,  TEC,  and  TARC  between  DFI  and
non-DFI  samples.  The  t-score  to  p-value  transfor-
mation was  performed  using  the  Student’s  T  cumu-
lative  distribution  function  (http://in-silico.net/
tools/statistics/).  The  regression  analysis  was  per-
formed to  examine  correlations  between  CRP
levels, and  the  number  of  antibiotic-resistant  iso-
lates in  DFI  and  non-DFI  ulcers  was  compared  using
the statistical  program  in  Microsoft  Excel;  2010,
USA.
w
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Table  1  Demographic  data  representing  sex,  age,  occupa
(DFI)  and  non-diabetic  foot  infection  (non-DFI)  study  groups
Sex Male  
Female  
Age ≤40  years  
≥40  years  
Occupation Daily  worker  
Business  
House  wife  
Farmer  
Service  
Service  Rtd  
Teacher  
Life  style Rural 
Urban  
Socio-Economic
Status
Low  —  income  (BDT  ≤5360)  
Lower  middle-income  (BDT  5361-21,27
Upper  middle-income  (BDT  21,271-65,
High-income  (BDT  ≥65,672)
BDT, Currency of Bangladesh.M.  Karmaker  et  al.
esults
emographic data of diabetic and
on-diabetic subjects
his  study  was  conducted  using  67  DFI  patients
nd 12  non-DFI  (control)  patients.  The  patients
ere grouped  according  to  their  sex  and  age  dis-
ribution,  occupation,  socio-economic  status  and
ifestyle (Table  1).  Most  of  the  patients  were  from
ural areas  (middle  income  family)  with  an  age
ange from  28  to  75  years  and  a mean  age  of
6.25 years.  Males  were  the  predominant  study  sub-
ects. Occupationally,  a majority  of  DFI  patients
ere small-scale  businessmen  (39%)  and  house-
ives (21%).  Among  non-DFI  patients,  91.6%  were
aily workers  (Table  1).
Microbiological  analyses  of  pus  samples  from
iabetic (67  samples)  and  non-diabetic  (12  sam-
les) foot  infections  were  performed  to  determine
he total  viable  bacterial  count  (TVBC),  the
otal Enterobacteriaceae  count  (TEC)  and  the
otal antibiotic  resistant  count  (TARC)  using  the
ntibiotic  supplements  CIP  (0.16  g/ml)  and  CTX
1 g/ml)  or  both  antibiotics  supplemented  within
A and  MAC  media.  The  bacterial  load  (TVBC,  TEC,
ARC) in  DFI  was  higher  than  that  in  non-DFI  samples
ith a  signiﬁcance  level  of  p <  0.01  (Fig.  1A).
A total  of  213  bacteria  were  isolated  from
7 DFI  pus  samples,  whereas  131  bacteria  were
btained  from  the  10  non-DFI  specimens  (two
tion,  socioeconomic  status  of  diabetic  foot  infection
.
DFI  patients  (67)  Non-DFI  patients  (12)
47(70%)  11(91.6%)
20(30%)  1(8.33%)
4  (6%)  9(75%)
63(94%)  3(25%)
5(7%)  11(91.6%)
26  (39%)  0
14(21%)  1(8.3%)
7(10%)  0
4(6%)  0
8(12%)  0
3(4%)  0
47(70%)  11(91.6%)
20(30%)  1(8.33%)
9(13%)  1(8.33%)
0)  46(69%)  11(91.6%)
671)  12(18%)  0
0  0
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Figure  1  A:  Total  viable,  Enterobacteriaceae  and  resistance  bacterial  count  of  pus  samples  from  diabetic  and  non-
diabetic  foot  infection  patients.  The  error  bars  indicate  the  standard  deviation.  The  standard  deviation  was  calculated
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on-diabetic  foot  infections.  The  presumptive  genera  we
on-DFI  specimens  were  bacterial  culture  neg-
tive).  According  to  their  phenotypes  (colony
orphology, gram  staining,  biochemical  properties,
nd sugar  fermentations),  different  morphological
ypes were  obtained.  For  population  composition
nalysis, all  of  the  isolates  belonged  to  groups
—10 (nine  DFI  and  seven  non-DFI  isolates).  The
solates  were  further  extensively  characterized
p to  the  genus  level  following  standard  guide-
ines [11]  using  clustering  software  BioCluster
.0 (www.Microbialgen.du.ac.bd/BioCluster). The
rganisms belonging  to  each  morphogroup  were
s follows:  group  1,  Staphylococcus  spp.;  group
, Pseudomonas  spp.;  group  3,  Enterococcus  spp.;
roup 4,  Enterobacter  spp.;  group  5,  Klebsiella
pp.; group  6,  Acinetobacter  spp.;  group  7,  Bacillus
pp.; group  8,  Citrobacter  spp.;  group  9,  Pro-
eus spp.;  and  Providentia  spp.;  and  group  10,
d
2
o
prial  genera  within  pus  samples  of  (a)  diabetic  and  (b)
etermined  according  to  biochemical  tests.
lcaligenes  spp.  (Fig.  1B,  Supplementary  materials
able  S2).
olecular characterization and genotyping:
RDRA, sequencing and phylogenetic
nalysis
RDRA  of  the  PCR  products  (approximately  1400  bp)
f the  different  isolate  morphogroups  using  the
estriction  enzyme  HhaI  revealed  different  restric-
ion patterns,  and  the  combined  restriction  frag-
ents for  each  restricted  amplicon  were  1400  bp in
otal. ARDRA  of  10  morphogroups  demonstrated  a
istinct genotypic  pattern  except  for  morphogroup
 (Supplementary  materials  Table  S4),  the  isolates
f which  displayed  ﬁve  different  patterns  (Sup-
lementary  materials  Fig.  S1).  From  each  of  the
272  M.  Karmaker  et  al.
Table  2  Maximum  identity  proﬁle  of  16S  rRNA  gene  sequences  of  isolates  according  to  BLAST  identiﬁcation.
Morph
groups
Isolates  no  Accession
numbers
Close  similarity  to  (accession  numbers)  %  Maximum
identity
Group1  39DMH3  Diabetic  (KM025375)  Staphylococcus  epidermidisY76 (JX067904)  99%
Group2 47DMAC2  Diabetic  (KM025388)  Pseudomonas  aeruginosa  C1501  (KF976394)  100%
54DMH1  Diabetic  (KM025368)  Pseudomonas  stutzeri  TH-31  (KF783212)  100%
45DCIP  +  CEF1  Diabetic (KM025370)  Pseudomonas  monteilii  EU45  (JF681286)  100%
48DMH1 Diabetic (KM025369)  Pseudomonas  pseudoalcaligenes  Z170
(KF835816)
99%
50DSWAB1  Diabetic  (KM025371)  Pseudomonas  hibiscicola  cp17  (JN082269)  100%
Group3  41DMH2  Diabetic  (KM025376)  Enterococuccus  faecalis  CV7  (KF7224942)  100%
Group4  44DMH1  Diabetic  (KM025389)  Enterobacter  hormaechei  WW2  (JN993998)  100%
Group5  49DSWAB2  Diabetic  (KM025377)  Klebsiella  pneumoniae  zg2010  (JX435602)  100%
Group6  44DMH2  Diabetic  (KM025378)  Acinetobacter  baumannii  OIFC143
(JN668837)
100%
Group7 46DMH2  Diabetic  (KM025374)  Bacillus  cereus  HS3  (KF922378)  99%
44DSWAB2  Diabetic  (KM025373)  Bacillus  circulans  I1  (FJ009417)  100%
Group8 2CMH3  Nondiabetic  (KM025386)  Citrobacter  sp.  R5-325  (JQ659727)  99%
4CCIP1  Nondiabetic  (KM025381)  Escherichia  coli  c120  (JQ781608)  99%
Group9 5CMAC1  Nondiabetic  (KM025382)  Providencia  stuartii  S2SA-Sa  (JQ828866)  99%
56DMH1 Diabetic (KM025372)  Proteus  mirabilis  FUA1263  (JN102554)  99%
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10  morphogroups  and  corresponding  ARDRA  groups,
27 representative  isolates  were  randomly  selected
for detailed  16S  rRNA  gene  sequence  analysis.
Maximum identity  proﬁles  of  the  16S  rRNA  gene
sequences of  the  isolates  according  to  BLAST  iden-
tiﬁcation  are  given  in  Table  2. The  phylogenetic
trees of  gram-positive  and  gram-negative  isolates
are presented  in  Figs.  2 and  3,  respectively.
Antibiogram of the isolated bacterial
populations
An  antibiogram  was  performed  of  DFI  and  non-
DFI isolates  using  21  commonly  used  antibiotics
belonging to  12  different  groups  (Table  S1).  Bacte-
ria isolated  from  DFI  samples  were  more  resistant
to most  antibiotics  than  bacteria  that  had  been  iso-
lated from  non-DFI  samples.  Staphylococcus  spp.
that had  been  isolated  from  DFI  patients  were
100% resistant  to  the  monobactam  (ATM)  group
of antibiotics  and  67%  resistant  to  the  penicillin-
G (PEN)  group  of  antibiotics.  However,  non-DFI
isolates were  100%  sensitive  to  penicillin.  Pseu-
domonas spp.  DFI  isolates  were  33%,  72%  and  78%
resistant  to  the  carbapenem  (IPM),  cephalosporin
(CAZ, CRO,  CXM)  and  monobactam  (ATM)  groups
of antibiotics,  respectively,  in  contrast  to  non-DFI
isolates,  for  which  these  values  were  8%,  62%,
and 69%,  respectively.  Enterobacter  spp.  isolated
from  both  DFI  and  non-DFI  patients  demonstrated
a similar  pattern  of  resistance  to  penicillin  (PEN),
monobactam (ATM)  and  cephalosporin  (CAZ,  CRO,
r
r
p
wigenes  faecalis  SH184  (KC172063)  99%
XM)  antibiotic  groups.  Acinetobacter  spp.  isolated
rom DFI  were  86%  resistant  to  penicillin  (PEN)  and
ephalosporin  (CAZ,  CRO,  CXM)  antibiotic  groups
n contrast  to  non-DFI  isolates,  which  were  57%
esistant.  Bacillus  spp.  isolated  from  DFI  and  non-
FI were,  respectively,  88%  and  50%  resistant  to
TM, cephalosporin  (CAZ,  CRO,  CXM),  and  peni-
illin (PEN)  antibiotic  groups.  Citrobacter  spp.  that
ere isolated  from  both  DFI  and  non-DFI  patients
ere 100%  resistant  to  the  cephalosporin  antibiotic
roup. However,  on  average,  82%  of  DFI  isolates
nd 90%  of  non-DFI  isolates  were  sensitive  to  the
arbapenem  (IPM)  antibiotic  group.
nalysis of C-reactive protein
he  normal  range  of  CRP  levels  in  human  serum
s ≤10  mg/L  [15]. In  DFI  patients,  serum  CRP  lev-
ls ranged  from  11.1  to  201  mg/L  (mean  value
3.80 ±  49.93  mg/L);  however,  in  non-DFI  patients,
he levels  ranged  from  9.1  to  96.5  mg/L  (mean
alue 47.73  ±  37.84  mg/L),  and  in  healthy  controls,
he levels  were  4—6.25  mg/L  (Fig.  4A).
The  CRP  values  increased  with  chronic  DFI
nd non-DFI  patient  history  and  concomitantly
hanged the  microbe  composition  in  our  samples.
e therefore  investigated  the  relationship  among
he composition  of  the  bacterial  population,  the
esistance  pattern  and  CRP  values.  The  ﬁndings
evealed the  following  pattern  (Table  1) —  (i)  DFI
atients  with  CRP  values  between  10  and  50  mg/L
ere commonly  infected  with  Pseudomonas  spp.,
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Figure  2  Phylogenetic  tree  of  16S  rRNA  gene  sequences  of  Gram-positive  isolates  from  diabetic  and  non-diabetic
patient  foot  infections  (Accession  number  shown  in  bold).  The  tree  was  generated  in  the  MEGA  4  program  using  the
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weighbor-joining  algorithm;  the  Treponema  pallidum  seq
eplicates)  are  shown  at  branch  nodes,  and  the  scale  bar
nterobacter  spp.  and  Klebsiella  spp.  and  were
esistant  to  seven  groups  of  antibiotics.  In  contrast,
on-DFI patients  with  CRP  values  between  10  and
0 mg/L  were  commonly  infected  with  Acinetobac-
er spp.  and  were  resistant  to  six  antibiotic  groups;
ii) DFI  patients  with  CRP  values  between  50  and
00 mg/L  were  commonly  infected  with  Enterobac-
er spp.,  Klebsiella  spp.  and  Pseudomonas  spp.  and
ere resistant  to  nine  antibiotic  groups.  Non-DFI
atients with  CRP  values  between  50  and  100  mg/L
ere commonly  infected  with  Pseudomonas  spp.,
itrobacter  spp.,  and  Staphylococcus  spp.  and  were
esistant to  eight  antibiotic  groups;  and  (iii)  DFI
atients  with  CRP  values  >100  mg/L  were  com-
only infected  with  Bacillus  spp.  and  Pseudomonas
pp. and  were  resistant  to  more  than  12  groups  of
ntibiotics.  Data  regression  analysis  revealed  a cor-
elation in  DFI  samples  with  r =  0.656,  p  <  0.01  and
on-DFI  r =  0.0387,  p  <  0.26  (Fig.  4B)  (Table  3).iscussion
he  pathophysiological  and  metabolic  differences
n DFI  and  non-DFI  patients  indicates  that  there
n
c
p
eces  served  as  the  out  group.  Bootstrap  values  (n  =  1000
esents  the  number  of  changes  per  nucleotide  position.
ay  be  a  difference  in  bacterial  population  com-
ositions.  To  address  this  hypothesis,  in  this
nvestigation,  we  analyzed  bacteria  in  pus  samples
rom  67  DFI  and  12  non-DFI  patients.  The  small
umber of non-DFI  patient  samples  compared  with
FI-patient  samples  in  this  investigation  was  due
o low  abundance  of  non-DFI  patients  compared
ith DFI  patients.  In  our  study,  we  determined  that
iabetic patients  older  than  40  years  of  age  were
ore  susceptible  to  foot  infection,  whereas  this
alue for  non-DFI  patients  was  less  than  40  years
f age.  The  average  age  of  DFI-patients  was  58
ears, and  these  patients  were  mostly  male.  Our
tudy revealed  that  most  of  the  DFI  patients  were
rom rural  areas  (lower  middle  income  family),  and
he majority  of  them  were  using  tube  well  water.
 majority  (39%)  of DFI  patients  were  small-scale
usinessmen, and  21%  were  housewives.  How-
ver, 91.6%  of  the  non-DFI  patients  were  daily
orkers.
Approximately, 93.3%  and  83.3%  of  DFI  andon-DFI pus  specimens,  respectively,  displayed
ulture-positive  results;  however,  the  bacterial
opulation compositions  were  distinctly  differ-
nt in  DFI  patient  pus  samples  compared  to  the
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Figure  3  Phylogenetic  tree  of  16S  rRNA  gene  sequences  of  Gram-negative  isolates  from  diabetic  and  non-diabetic
patient  foot  infections  (Accession  number  shown  in  bold).  The  tree  was  generated  in  the  MEGA  4  program  using  the
quen
 repr
[
n
nneighbor-joining  algorithm;  the  Treponema  pallidum  se
replicates)  are  shown  at  branch  nodes,  and  the  scale  bar
samples  from  non-DFI  patients.  Among  the  iso-
lates, gram-negative  organisms  were  predominant
in both  patients.  These  results  are  compatible
with the  ﬁndings  of  previous  studies  [16,17].
However,  a  recent  study  found  a predominance
of Gram-positive  organisms  in  non-DFI  patients
b
l
o
Figure  4  A:  Average  serum  C  reactive  protein  levels  in  diab
serum  CRP  levels  and  no  antibiotic  resistance  by  (a)  diabetic  ces  served  as  an  out  group.  Bootstrap  values  (n  =  1000
esents  the  number  of  changes  per  nucleotide  position.
18]. Our  study  demonstrated  that  most  DFI  and
on-DFI patient  infections  were  polymicrobial  in
ature. The  statistical  calculation  (comparative
acterial signiﬁcance  analysis  at  90%  conﬁdence
evel) revealed  that  the  rate  of  occurrence
f three  organisms,  namely,  Enterococcus  spp.
etic  and  non-diabetic  patients.  B:  Correlation  between
and  (b)  non-diabetic  isolates.
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Table  3  Correlation  between  serum  CRP  levels,  organism  growth  and  degree  of  antibiotic  resistance.  (a)  Diabetic
patients  and  (b)  non-diabetic  patients.
CRP  value  range  (mg/L)  Common  organism  growth  No  of  antibiotics  commonly  resistance  Groups
(a)  Correlation  with  DFI  isolate  resistance  pattern  and  CRP  levels
10—50 Pseudomonas  spp. AMC,  ATM,  AMP,CAZ,CRO,
CXM,CFM,CN,DO  (9) 7Enterobacter  spp.
Klebsiella  spp.
50—100 Pseudomonas  spp. AMC,  ATM,  AMP,  CRO,  CXM,  CTX,  CN,
IPM,PB,DO  (10) 8Enterobacter  spp.
>100 Bacillus  spp. AK,AMC,ATM,AMP,AZM,CAZ,CRO,CXM,
CIP,C,CTX,IPM,CFMF,CO,DA,RD,PB  (18) 12Pseudomonas  spp.
(b)  Correlation  with  non-DFI  isolate  resistance  patterns  and  CRP  levels
10—50  Pseudomonas  spp.  AMC,  ATM,  AMP,  AZM,CAZ,CRO,
CXM,CTX,CFM  (9)
6
50—100 Pseudomonas  spp. AMC,  AMP,  AZM,CAZCRO,CXM,
CIP,C,CTX,DO,CO,DA  (11) 8Citrobacter  spp.
Staphylococcus  spp.
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cZ|  =  2.2125,  Klebsiella  spp.  |Z|  =  1.732,  and  Bacil-
us spp.  |Z|  =  1.9034,  were  signiﬁcant  in  DFI  patients
ompared  with  non-DFI  patients.  However,  in  non-
FI patients,  the  rate  of  occurrence  of  Citrobacter
pp. |Z|  =  14.1901  was  signiﬁcant.  Common  genera
ound  in  both  DFI  and  non-DFI  include  Pseudomonas
pp., Staphylococcus  spp.  and  Acinetobacter  spp.
hese polymicrobial  infections  are  responsible  for
hronic wounds  and  more  complex  infections.
Through  phenotypic  and  genotypic  characteriza-
ion, it  was  observed  that  there  were  ﬁve  strains  of
seudomonas  spp.  obtained  from  DFI,  including  P.
eruginosa, P.  stutzeri,  P.  pseudoalcaligens,  P.  mon-
eilii, and  P.  hibiscicola  (Fig.  3).  In  this  study,  Ent.
ormaechei  were  the  predominant  organism  (22%)
n DFI  isolates  and  occurred  in  low  (6%)  numbers  in
on-DFI isolates.  Citrobacter  spp.  are  opportunistic
osocomial pathogens  that  cause  5%  of  infections  in
mmune-compromised  patients  [16].  In  our  study,
he prevalence  of  Citrobacter  spp.  was  33%  in  non-
FI; however,  the  prevalence  was  only  2%  in  DFI.
he prevalence  of  B.  cereus  was  17%  in  DFI  and  3%
n non-DFI  patients.  In  our  study,  Enterococci  spp.
9%) and  Klebsiella  spp.  (7%)  were  found  in  DFI  pus
amples, whereas  these  values  were  reported  to
e 14.9%  and  20.5%,  respectively,  elsewhere  [19].
taphylococcus  species  comprised  13%  of  isolates  in
oth DFI  and  non-DFI  patients.  A.  baumannii  is  an
mportant  nosocomial  pathogen  [20]. In  our  study,
. baumannii  demonstrated  a  similar  percentage
10%) in  both  DFI  and  non-DFI  patients.  However,
n many  studies,  33%  of  A.  baumannii  strains  were
solated  from  DFI  patients  [21,22].
a
n
gDFI  patients  have  chronic  non-healing  ulcers  due
o several  underlying  factors  such  as  poor  glycemic
ontrol, peripheral  neuropathy,  poor  blood  supply
o the  extremities  and  polymicrobial  infections  in
heir feet.  These  factors  lead  to  CSI  and  delay
he healing  process  [4,9,23]. Different  pathogen
ypes are  associated  with  different  inﬂammatory
esponses, and  patients  who  were  infected  with
ram-negative  organisms  have  high  CRP  levels.
FI patients  with  CSI  are  always  treated  (long
erm) with  a  combination  of  antibiotics  because  the
icrobes are  highly  resistant  to  different  antibiotic
roups  [24,25].  In  the  present  investigation,  the
acterial population  associated  with  DFI  was  com-
aratively  more  resistant  to  antibiotics  than  were
he non-DFI  isolates.  CRP  values  in  DFI  patients
ere positively  correlated  with  the  bacterial  pop-
lation and  antibiotic  resistance  properties  of  the
solated bacteria  from  DFI  patients  in  our  study.
here was  a  predominance  of  Gram-negative  orga-
isms in  pus  samples  from  patients  with  high  CRP
evels. We  observed  that  DFI  patients  who  were
ommonly infected  with  Pseudomonas  spp.  and
acillus  spp.  had  high  CRP  levels.  This  result  is
ompatible  with  ﬁndings  from  others  [26].  Bacil-
us spp.  and  Pseudomonas  spp.  that  were  isolated
rom  DFI  patients  were  resistant  to  more  than  12
roups of  antibiotics.  Non-DFI  patients  who  were
nfected  with  Pseudomonas  spp.  and  Staphylococ-
us spp.  had  high  CRP  levels.  Pseudomonas  spp.
nd Staphylococcus  spp.  that  were  isolated  from
on-DFI  patients  were  commonly  resistant  to  eight
roups of  antibiotics.
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Our  study  revealed  a  signiﬁcant  correlation
between  MDR  organism  growth  in  foot  infections
and high  serum  CRP  levels.  We  observed  that
patients infected  with  MDR  microbes  had  high
serum CRP  levels.  These  ﬁndings  are  comparable
with other  studies  [9,27]. Consequently,  we  can
assume that  the  growth  of  Gram-negative  MDR
organisms in  patients’  foot  infections  inﬂuences
serum CRP  levels.
Conclusions
This  investigation  demonstrates  a  complex  associ-
ation of  the  bacterial  population  in  DFI  patients
compared with  non-DFI  patients  with  different
antimicrobial resistance  patterns,  which  are  linked
with CRP  levels.  An  altered  microbial  composi-
tion was  observed  in  DFI  and  non-DFI  patients.
The microbiome  associated  with  DFI  and  non-
DFI patients  demonstrate  MDR  properties  at  an
alarming  rate.  This  investigation  also  explores  the
correlation  of  serum  CRP  levels  with  microbial
compositions  and  their  resistance  properties.  This
study is  expected  to  generate  valuable  information,
which will  be  helpful  in  the  management  and  pre-
vention  of  foot  infections  in  our  population  and  will
help clinicians  to  select  and  develop  appropriate
drugs.
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